-- Earnings Flash (XOMA) XOMA CORPORATION Posts Q1 Revenue $3.1M
7:33AM ET 5/05/2022 MT Newswires...
...
James R Neal, Director, CEO, on March 21, 2022, sold 53,450 shares in Xoma (XOMA) for $1,553,807. Following the Form 4 filing with the SEC, Neal has...
...
XOMA (XOMA) said Thursday Jim Neal is retiring as CEO of the biotech company and has been named chairman of the board, succeeding W. Denman Van Ness,...
Address | 2200 Powell Street Emeryville, California 94608 |
Phone | +1.510.204.7200 |
Number of Employees | 11 |
Recent SEC Filing | 05/05/2022![]() |
Chairman & Chief Executive Officer | James R. Neal |
Chief Financial Officer & Senior VP-Finance | Thomas Burns |
Investor Relations Contact | Juliane Snowden |
Price Open | $17.81 |
Previous Close | $17.86 |
52 Week Range | $16.96 - 39.02 |
Market Capitalization | $204.0 M |
Shares Outstanding | 11.4 M |
Sector | Health Technology |
Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/04/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | 32.47 |
Earnings per Share | $0.57 |
Beta vs. S&P 500 | N/A |
Revenue | $5.3 M |
Net Profit Margin | 29.73% |
Return on Equity | 9.54% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |